Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis.
Fiche publication
Date publication
janvier 2017
Journal
Alimentary pharmacology & therapeutics
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN
Lien Pubmed
Résumé
Crohn's disease (CD) and ulcerative colitis (UC) have a progressive course leading to hospitalisation and surgery. The ability of existing therapies to alter disease course is not clearly defined.
Mots clés
Biological Products, therapeutic use, Colitis, Ulcerative, diagnosis, Crohn Disease, diagnosis, Hospitalization, trends, Humans, Immunosuppressive Agents, therapeutic use, Randomized Controlled Trials as Topic, methods, Treatment Outcome
Référence
Aliment. Pharmacol. Ther.. 2017 01;45(1):3-13